Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

Slides:

Advertisements

Similar presentations

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Advertisements

Photodynamic Laser Therapy for Lesions in the Airway

Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S

Persistent Effect of Red Cell Transfusion on Health-Related Quality of Life After Cardiac Surgery Colleen Gorman Koch, MD, MS, Farah Khandwala, MS, Liang.

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,

Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K

Constantin Stefanidis, MD, Albert M

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C

Niv Ad, MD, Linda Henry, PhD, Sharon Hunt, MBA, Sari D. Holmes, PhD

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Pacemaker Therapy After Tricuspid Valve Operations: Implications on Mortality, Morbidity, and Quality of Life Janne J. Jokinen, MD, Anu K. Turpeinen,

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma Giulio Melloni, MD, Claudio.

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Lung Metastases From Colorectal Cancer: Analysis of Prognostic Factors in a Single Institution Study Maria Giulia Zampino, MD, Patrick Maisonneuve, Eng,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Loretta Erhunmwunsee, MD, Brian C

Persistent Effect of Red Cell Transfusion on Health-Related Quality of Life After Cardiac Surgery Colleen Gorman Koch, MD, MS, Farah Khandwala, MS, Liang.

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Brendon M. Stiles, MD, Farooq Mirza, MD, Jeffrey L. Port, MD, Paul C

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

Full-Thickness Resection With Myocutaneous Flap Reconstruction for Locally Recurrent Breast Cancer Godehard Friedel, MD, FETCS, Thomas Kuipers, MD, Jürgen.

Readmission to Intensive Care Unit After Initial Recovery From Major Thoracic Oncology Surgery Suk-Won Song, MD, Hyun-Sung Lee, MD, PhD, Jae-Hyun Kim,

Long-Term Outcomes After Surgical Resection of Pulmonary Metastases From Colorectal Cancer Hisashi Suzuki, MD, PhD, Moriyuki Kiyoshima, MD, Miyuki Kitahara,

Resection of Intraabdominal Tumors With Cavoatrial Extension Using Deep Hypothermic Circulatory Arrest Christopher Lau, MD, Padraic O’Malley, MD, Mario.

Lung Cancer and Its Operable Brain Metastasis: Survival Rate and Staging Problems József Furák, MD, PhD, Imre Troján, MD, Tamás Szöke, MD, László Agócs,

Dylan R. Nieman, MD, PhD, Christian G. Peyre, MD, Thomas J

Right Ventricular Systolic Dysfunction Assessed by Cardiac Magnetic Resonance Is a Strong Predictor of Cardiovascular Death After Coronary Bypass Grafting

Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis Bryan A. Whitson, MD, PhD, Shawn S.

Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.

Use of Amiodarone After Major Lung Resection

Does Repeated Lung Resection Provide Long-Term Survival for Recurrent Pulmonary Metastases of Colorectal Cancer? Results of a Retrospective Japanese Multicenter.

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection Po-Kuei Hsu, MD, Chien-Sheng Huang,

Prolonged Overall Survival After Pulmonary Metastasectomy in Patients With Breast Cancer Georgios Meimarakis, MD, Dominik Rüttinger, MD, PhD, Joachim.

Primary Cardiac Sarcoma

Radiofrequency Ablation for the Treatment of Pulmonary Metastases

Heterogeneity of Tumor Sizes in Multiple Pulmonary Metastases of Colorectal Cancer as a Prognostic Factor Tomohiro Maniwa, MD, Keita Mori, PhD, Yasuhisa.

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki,

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Surgical Treatment for Limited-Stage Primary Small Cell Cancer of the Esophagus Dongrong Situ, MD, Yongbin Lin, MD, PhD, Hao Long, MD, PhD, Lanjun Zhang,

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

Douglas E. Paull, MD, Glenda M. Updyke, PA-C, Michael A

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Early Intrapulmonary Recurrence After Pulmonary Metastasectomy Related to Colorectal Cancer Mi Ri Hwang, MD, Ji Won Park, MD, Dae Yong Kim, MD, Hee Jin.

Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer Shanda H. Blackmon, MD, MPH, Elizabeth.

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter? Anthony W. Kim, MD, L. Penfield Faber, MD, William.

Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant Ryan R. Davies, MD, Shylah Haldeman,

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases Marc Riquet, MD, PhD, Patrick Bagan,

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Detailed Analysis of Prognostic Factors in Primary Esophageal Small Cell Carcinoma Wei-Wei Chen, MD, Feng Wang, MD, PhD, ShaoBin Chen, MD, Luhua Wang,

Bryan M. Burt, MD, Santiago Ocejo, MD, Carlos M

Presentation transcript:

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas, MD, FETCS, Stefan Sponholz, MD, Natalie Kudelin, MD, Michael Eberlein, MD, PhD, Joachim Schirren, MD The Annals of Thoracic Surgery Volume 97, Issue 6, Pages 1926-1932 (June 2014) DOI: 10.1016/j.athoracsur.2014.02.026 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Overall survival: survivor function (black line). (Gray-shaded area = 95% confidence interval.) The Annals of Thoracic Surgery 2014 97, 1926-1932DOI: (10.1016/j.athoracsur.2014.02.026) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Survival depending on N status: N0 (solid line), median survival 78 months; and N1/2 (dashed line), median survival 44 months (p = 0.03). (Gray-shaded areas = 95% confidence interval.) The Annals of Thoracic Surgery 2014 97, 1926-1932DOI: (10.1016/j.athoracsur.2014.02.026) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Survival depending on primary tumor location: colon cancer (solid line), median survival 92 months; rectal cancer (dashed line), median survival 40 months (p < 0.001). (Gray-shaded areas = 95% confidence interval.) The Annals of Thoracic Surgery 2014 97, 1926-1932DOI: (10.1016/j.athoracsur.2014.02.026) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Survival depending on response to chemotherapy before metastasectomy: progress (solid line), median survival 15 months; stable disease/partial response (SD/PR [dotted line]), median survival 63 months (p < 0.001). (Gray-shaded areas = 95% confidence interval.) The Annals of Thoracic Surgery 2014 97, 1926-1932DOI: (10.1016/j.athoracsur.2014.02.026) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions